Home Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain By - September 27, 2022 40 0 Facebook Twitter Pinterest WhatsApp The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Apple Watch Series 8 adds ovulation estimates, car crash detection Pilots - September 8, 2022 0 Derma AI Cureskin bags $20M Series B funding and more funding from India Pilots - March 15, 2024 0 ‘Small language’ AI detects depression in Korea Pilots - September 19, 2024 0 South Korea clears stroke AI and more briefs Pilots - June 7, 2024 0 Samsung Galaxy Watch receives FDA clearance for AFib monitoring Pilots - May 10, 2023 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3